Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)

bio.bobby

bio.bobby
27 Followers
0 Following
Send Message
View as an RSS Feed
View bio.bobby's Comments BY TICKER:
Latest  |  Highest rated
  • OncoSec's And Ziopharm's IL-12 Targeted Delivery Systems: Which Will Succeed? [View article]
    : it's merely a matter of proven results"

    Really? How many electroporation drugs are on the market? Why not, the technology has been around for decades.
    Jun 17 01:13 PM | 0 Likes Like |Link to Comment
  • OncoSec's And Ziopharm's IL-12 Targeted Delivery Systems: Which Will Succeed? [View article]
    "electroporation has a very bright future in cancer treatment"

    How long have these guys been pumping this electroporation crap?
    Jun 17 08:47 AM | 0 Likes Like |Link to Comment
  • 6 New Bearish Celsion Myths Destroyed [View article]
    "Nothing has changed fundamentally since phase III data release, nothing. "

    correct. clsn was worth .9 cents after phase 3 failed, and thats liklye still too high.
    Jun 14 01:16 PM | 0 Likes Like |Link to Comment
  • 6 New Bearish Celsion Myths Destroyed [View article]
    " Much too dangerous to short right now, much. "

    naw, this pig is worthless. was a great short at 1.9, still a great short in 1.3s.
    Jun 14 01:14 PM | 0 Likes Like |Link to Comment
  • OncoSec's And Ziopharm's IL-12 Targeted Delivery Systems: Which Will Succeed? [View article]
    ONCS versus ZIOP, talk about a horse race to the glue factory.
    Jun 14 09:45 AM | 1 Like Like |Link to Comment
  • Analysis Of Celsion's Press Release Shows Extended Risks [View article]
    " I agree that the company is likely to use subgroup analysis to form the basis for new trials"

    Of course, this is how the crap biotech game is played. A new trial = 2-3+ more years of $400,000 salary for the CEO.

    Look how long garbage companies like ONTY, ONCY, and ZIOP have been able to keep fleecing retail investors.

    Turdmodox is a just silly.
    Jun 14 09:44 AM | 0 Likes Like |Link to Comment
  • Analysis Of Celsion's Press Release Shows Extended Risks [View article]
    " Celsion's recent press release, which oddly enough never says what was misleading about our last article"

    Is it really odd, or is it just acknowledgment that there was nothing misleading about your last article? Presumably if there were, CLSn would have refuted?????
    Jun 13 04:40 PM | 0 Likes Like |Link to Comment
  • 6 New Bearish Celsion Myths Destroyed [View article]
    Actually, the author's insistence that CLSN's booth at ASCO meant somethign is funnier....
    Jun 13 08:38 AM | 0 Likes Like |Link to Comment
  • 6 New Bearish Celsion Myths Destroyed [View article]
    This guy's was foolish enough to believe the cooked liver story before the failed phase 3 study

    http://bit.ly/11VMkTK

    http://seekingalpha.co...

    " I'm standing with my long position in Celsion come hell or high water"......
    Jun 12 08:38 AM | 3 Likes Like |Link to Comment
  • Ampio Pharmaceuticals: 50 Shades Of Grey - Secondary On The Way [View article]
    "I addressed yours and Bobby's questions an hour ago"

    Please try again. I am sure your answer is illuminating.
    Jun 12 08:33 AM | 2 Likes Like |Link to Comment
  • Ampio Pharmaceuticals: 50 Shades Of Grey - Secondary On The Way [View article]
    "THIS IS A HISTORICAL FACT WRITTEN IN OUR OPHTHALMOLOGY TEXT BOOKS."

    Can you please provide a specific reference, i.e. text and page #?

    Thanks.
    Jun 12 08:32 AM | 0 Likes Like |Link to Comment
  • Ampio Pharmaceuticals: 50 Shades Of Grey - Secondary On The Way [View article]
    "I am a Physician"

    Of course you are. I'm a physician, a physicist, and a phlebotomist.
    Jun 12 08:32 AM | 2 Likes Like |Link to Comment
  • Ampio Pharmaceuticals: 50 Shades Of Grey - Secondary On The Way [View article]
    " Within 3 months there will be extensive clinical data on AMPE's namesake drug Ampion & their diagnostic device."

    Really? What data do you expect from the "diagnostic device"? Best case, the only data AMPE will have is that one dose of ampion is as useless as the other.
    Jun 10 10:17 PM | 0 Likes Like |Link to Comment
  • Ampio Pharmaceuticals: 50 Shades Of Grey - Secondary On The Way [View article]
    Interesting. So what does it say that AMPE's phase 2 study did not show an improvement in VA?
    Jun 10 10:13 PM | 1 Like Like |Link to Comment
  • Ampio Pharmaceuticals: 50 Shades Of Grey - Secondary On The Way [View article]
    FDA guidance?

    AMPE claimed to have FDA guidance last year on AMpion, but then had to change their clinical plan in February. Why was that, if they had 'guidance' the prior May? AMPE got guidance on the phase 3 program for Zertane, and promised to start this in Q1 2013. They still haven;t started. How is it not clear that they have no intention to pursue this?
    Jun 9 10:50 PM | 0 Likes Like |Link to Comment
COMMENTS STATS
378 Comments
216 Likes